Inventor · Shannon, CA, US

Martin Trudeau

25Patents
16h-index
43Co-inventors
77Inventor score

Filing activity: Sep 19, 2001 → Dec 5, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US8410274B2 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide Emerging Cross-Sectional Technologies 92 Active
US6498178B2 Inhibitors of IMPDH enzyme Chemistry; Metallurgy 85 Expired
US8476442B2 Process for making modulators of cystic fibrosis transmembrane conductance regulator Emerging Cross-Sectional Technologies 81 Active
US8754224B2 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide Emerging Cross-Sectional Technologies 76 Active
US8765957B2 Process for making modulators of cystic fibrosis transmembrane conductance regulator Emerging Cross-Sectional Technologies 69 Active
US8835639B2 Process for making modulators of cystic fibrosis transmembrane conductance regulator Emerging Cross-Sectional Technologies 68 Active
US9139530B2 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide Emerging Cross-Sectional Technologies 59 Active
US9371287B2 Process for making modulators of cystic fibrosis transmembrane conductance regulator Emerging Cross-Sectional Technologies 53 Active
US9670163B2 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide Emerging Cross-Sectional Technologies 42 Active
US9751839B2 Process for making modulators of cystic fibrosis transmembrane conductance regulator Emerging Cross-Sectional Technologies 39 Active
US6632809B2 Gyrase inhibitors and uses thereof Emerging Cross-Sectional Technologies 38 Expired
US9931334B2 Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide Emerging Cross-Sectional Technologies 33 Active
USRE40245E1 Gyrase inhibitors and uses thereof General 26 Expired
US10537565B2 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide Emerging Cross-Sectional Technologies 21 Active
US7414046B2 Gyrase inhibitors and uses thereof Emerging Cross-Sectional Technologies 19 Expired
US7381827B2 Processes and intermediates Emerging Cross-Sectional Technologies 18 Active
US6608087B1 Gyrase inhibitors and uses thereof Emerging Cross-Sectional Technologies 14 Expired
US7087642B2 Inhibitors of IMPDH enzyme Chemistry; Metallurgy 8 Expired
US7432290B2 Inhibitors of IMPDH enzyme Chemistry; Metallurgy 5 Expired
US7652153B2 Caspase inhibitors and uses thereof Emerging Cross-Sectional Technologies 4 Active
US11291662B2 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide Emerging Cross-Sectional Technologies 4 Active
US7834200B2 Processes and intermediates Emerging Cross-Sectional Technologies 3 Active
US8293929B2 Processes and intermediates Emerging Cross-Sectional Technologies 3 Active
US6930116B2 Gyrase inhibitors and uses thereof Emerging Cross-Sectional Technologies 0 Expired
US8268873B2 Inhibitors of IMPDH enzyme Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.